![(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;
medetomidine 613-321-00-1 structure](https://www.ebi.ac.uk/opsin/ws/(RS)-4-%5B1-(2%2C3-dimethylphenyl)ethyl%5D-1H-imidazole%3B%0Amedetomidine%20613-321-00-1.png)
(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole; medetomidine 613-321-00-1
Name
(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole; medetomidine 613-321-00-1
Molecular Formula
C13H16N2
Identifiers
cas number 86347-14-0 PRIMARY
ec number 811-718-6
chemical name Medetomidine
chemical name (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;
medetomidine 613-321-00-1
GHS Hazard Pictograms
GHS09 
GHS08 
GHS06 Hazard Classifications
Acute Tox. 2
Danger
Acute toxicity (inhalation)
Hazard Code: H330
Category: Acute Tox. 2
Source: Harmonised C&L
STOT SE 3
Warning
Specific target organ toxicity — single exposure
Hazard Code: H336
Category: STOT SE 3
Source: Harmonised C&L
STOT SE 1
Danger
Specific target organ toxicity — single exposure
Hazard Code: H370
Category: STOT SE 1
Source: Harmonised C&L
STOT RE 1
Danger
Specific target organ toxicity — repeated exposure
Hazard Code: H372
Category: STOT RE 1
Source: Harmonised C&L
Aquatic Acute 1
Hazardous to the aquatic environment (acute)
Hazard Code: H400
Category: Aquatic Acute 1
Source: Harmonised C&L
Aquatic Chronic 1
Hazardous to the aquatic environment (long-term)
Hazard Code: H410
Category: Aquatic Chronic 1
Source: Harmonised C&L
Regulatory Lists (4)
ED LIST I: EU IDENTIFIED ENDOCRINE DISRUPTORS
ED List I — Substances identified as endocrine disruptors at EU level
RIVM ZZS (ZEER ZORGWEKKENDE STOFFEN)
RIVM ZZS (Zeer Zorgwekkende Stoffen) — Dutch list of Substances of Very High Concern maintained by the National Institute for Public Health and the Environment (RIVM), based on REACH SVHC criteria and CMR/PBT/ED properties
KEMI PRIO PHASE-OUT SUBSTANCES
KEMI PRIO Phase-Out Substances — Swedish Chemicals Agency list of substances with properties of very high concern that should be phased out
ENDOCRINE DISRUPTOR ASSESSMENT
ECHA Endocrine Disruptor assessment — Substances evaluated for endocrine-disrupting properties under REACH and CLP regulations
Disclaimer
The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.